Return to Transcripts main page
CNN Live At Daybreak
New Impotence Drug is Closer to FDA Approval
Aired May 30, 2003 - 06:41 ET
THIS IS A RUSH TRANSCRIPT. THIS COPY MAY NOT BE IN ITS FINAL FORM AND MAY BE UPDATED.
THIS IS A RUSH TRANSCRIPT. THIS COPY MAY NOT BE IN ITS FINAL FORM AND MAY BE UPDATED.
CAROL COSTELLO, CNN ANCHOR: It's time for a little business buzz right now. The little blue pill may soon get some competition.
For more on that, Susan Lisovicz is talking Viagra this morning.
SUSAN LISOVICZ, CNN FINANCIAL NEWS: We're talking Viagra, and it may be get competition from a little orange pill, Carol. An advisory panel to the Food and Drug Administration has ruled that the impotence drug, Levitra, does not pose major heart risks. This moves Levitra one step closer to being approved by the FDA and marketed here in the U.S.
The drug is made by the European companies, GlaxoSmithKline and Bayer, and has been selling in Europe since March. It's vying for Viagra's market share here. Viagra, made by Pfizer, has annual sales of $2 billion, a blockbuster drug.
And Levitra also has a little orange flame on the box as if the product itself isn't enough to get consumers' attention -- Carol.
COSTELLO: A little flame on the box, it's hot.
LISOVICZ: Yes.
COSTELLO: Yes. A quick look at...
LISOVICZ: In so many ways.
COSTELLO: Yes, exactly. A quick look at the futures before you go.
LISOVICZ: The futures are higher, I'm happy to say, Carol. The Dow industrials, however, could not make it six winning sessions in a row yesterday, ending nearly 1 percent lower. But the Nasdaq extended its gains for the fifth straight day, adding three-quarters of a percent. Nasdaq now up 18 percent on the year.
Economic news today, personal income, personal spending, a regional manufacturing report and the final reading from the University of Michigan consumer sentiment for May.
Wake up and smell the coffee, keep an eye on shares of Starbucks, which could get a jolt today. The world's largest coffee shop chain says sales at stores open at least a year up 7 percent in May from the year earlier. That's a good thing.
Back to you -- Carol.
COSTELLO: That's a great thing. Thank you, Susan Lisovicz, many thanks.
LISOVICZ: Have a great weekend.
COSTELLO: You, too.
TO ORDER A VIDEO OF THIS TRANSCRIPT, PLEASE CALL 800-CNN-NEWS OR USE OUR SECURE ONLINE ORDER FORM LOCATED AT www.fdch.com.
Aired May 30, 2003 - 06:41 ET
THIS IS A RUSH TRANSCRIPT. THIS COPY MAY NOT BE IN ITS FINAL FORM AND MAY BE UPDATED.
CAROL COSTELLO, CNN ANCHOR: It's time for a little business buzz right now. The little blue pill may soon get some competition.
For more on that, Susan Lisovicz is talking Viagra this morning.
SUSAN LISOVICZ, CNN FINANCIAL NEWS: We're talking Viagra, and it may be get competition from a little orange pill, Carol. An advisory panel to the Food and Drug Administration has ruled that the impotence drug, Levitra, does not pose major heart risks. This moves Levitra one step closer to being approved by the FDA and marketed here in the U.S.
The drug is made by the European companies, GlaxoSmithKline and Bayer, and has been selling in Europe since March. It's vying for Viagra's market share here. Viagra, made by Pfizer, has annual sales of $2 billion, a blockbuster drug.
And Levitra also has a little orange flame on the box as if the product itself isn't enough to get consumers' attention -- Carol.
COSTELLO: A little flame on the box, it's hot.
LISOVICZ: Yes.
COSTELLO: Yes. A quick look at...
LISOVICZ: In so many ways.
COSTELLO: Yes, exactly. A quick look at the futures before you go.
LISOVICZ: The futures are higher, I'm happy to say, Carol. The Dow industrials, however, could not make it six winning sessions in a row yesterday, ending nearly 1 percent lower. But the Nasdaq extended its gains for the fifth straight day, adding three-quarters of a percent. Nasdaq now up 18 percent on the year.
Economic news today, personal income, personal spending, a regional manufacturing report and the final reading from the University of Michigan consumer sentiment for May.
Wake up and smell the coffee, keep an eye on shares of Starbucks, which could get a jolt today. The world's largest coffee shop chain says sales at stores open at least a year up 7 percent in May from the year earlier. That's a good thing.
Back to you -- Carol.
COSTELLO: That's a great thing. Thank you, Susan Lisovicz, many thanks.
LISOVICZ: Have a great weekend.
COSTELLO: You, too.
TO ORDER A VIDEO OF THIS TRANSCRIPT, PLEASE CALL 800-CNN-NEWS OR USE OUR SECURE ONLINE ORDER FORM LOCATED AT www.fdch.com.
